We have observed
13 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PROCESS FOR CINACALCET HYDROCHLORIDE
NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM
BINDING DRUGS WITH NANOCRYSTALLINE CELLULOSE (NCC)
SALTS OF RALTEGRAVIR
METHOD FOR SEPARATING LIGNIN FROM BLACK LIQUOR
PROCESS FOR PREPARING TOLVAPTAN INTERMEDIATES
Yeast-based vaccines as immunotherapy
CELLULOSE-REINFORCED HIGH MINERAL CONTENT PRODUCTS AND METHODS OF MAKING THE SAME
PROCESS FOR OLMESARTAN MEDOXOMIL
Process for the preparation of moxonidine
A PROCESS FOR THE PREPARATION OF PAZOPANIB USING NOVEL INTERMEDIATE
A PROCESS FOR ETRA VIRINE INTERMEDIATE AND POLYMORPHS OF ETRAVIRINE
Crystalline forms of maraviroc phosphate as intermediates in the preparation of a maraviroc amorphous form